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Background: Annonacin, an annonaceous acetogenin isolated from Annona muricata has been 
reported to be strongly cytotoxic against various cell lines, in vitro. Nevertheless, its effect 
against in vivo tumor promoting activity has not been reported yet. Therefore, this study was 
aimed to investigate antitumor-promoting activity of annonacin via in vivo two-stage mouse 
skin tumorigenesis model and its molecular pathways involved. Methods: Mice were initiated 
with single dose of 7,12-dimethylbenz[α]anthracene (DMBA) (390 nmol/100 μL) followed by, 
in subsequent week, repeated promotion (twice weekly; 22 weeks) with 12-O-
tetradecanoylphorbol-13-acetate (TPA) (1.7 nmol/100 μL). Annonacin (85 nM) and curcumin 
(10 mg/kg; reference) were, respectively, applied topically to DMBA/TPA-induced mice 
30 min before each TPA application for 22 weeks. Upon termination, histopathological 
examination of skin, liver and kidney as well as genes and proteins expression analysis were 
conducted to elucidate the potential mechanism of annonacin. Results: With comparison to the 
carcinogen control, Annonacin significantly increased the tumor latency period and reduced 
the tumor incidence, tumor burden and tumor volume, respectively. In addition, it also 
suppressed tumorigenesis manifested by significant reduction of hyperkeratosis, dermal 
papillae and number of keratin pearls on skin tissues. Annonacin also appeared to be non-toxic 
to liver and kidney. Significant modulation of both AKT, ERK, mTOR, p38, PTEN and Src 
genes and proteins were also observed in annonacin-targeted signaling pathway(s) against 
tumorigenesis. Conclusions: Collectively, results of this study indicate that annonacin is a 
potential therapeutic compound targeting tumor promoting stage in skin tumorigenesis by 
modulating multiple gene and protein in cancer signaling pathways without apparent toxicity. 
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